Aβ*56 is a stable oligomer that correlates with age-related memory loss in Tg2576 mice

Amyloid-β (Aβ) oligomers consist of fibrillar and non-fibrillar soluble assemblies of the Aβ peptide. Tg2576 human amyloid precursor protein (APP)-expressing transgenic mice modeling Alzheimer’s disease produce Aβ*56, a non-fibrillar Aβ assembly that has been shown by several groups to relate more closely to memory deficits than plaques. Previous studies did not decipher specific forms of Aβ present in Aβ*56. Here, we confirm and extend the biochemical characterization of Aβ*56. We used anti-Aβ(1-x), anti-Aβ(x-40), and A11 anti-oligomer antibodies in conjunction with western blotting, immunoaffinity purification, and size-exclusion chromatography to probe aqueous brain extracts from Tg2576 mice of different ages. We found that Aβ*56 is a ∼56-kDa, SDS-stable, A11-reactive, non-plaque-related, water-soluble, brain-derived oligomer containing canonical Aβ(1-40) that correlates with age-related memory loss. The unusual stability of this high molecular-weight oligomer renders it an attractive candidate for studying relationships between molecular structure and effects on brain function.

[1]  V. Daggett,et al.  SOBA: Development and testing of a soluble oligomer binding assay for detection of amyloidogenic toxic oligomers , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Siemers,et al.  ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease , 2022, Frontiers in Neuroscience.

[3]  V. Daggett,et al.  Amyloid- β Oligomers: Multiple Moving Targets , 2022 .

[4]  J. Collinge,et al.  Highly infectious prions are not directly neurotoxic , 2020, Proceedings of the National Academy of Sciences.

[5]  Y. Suh,et al.  Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer’s disease , 2020, Scientific Reports.

[6]  K. Ashe The biogenesis and biology of amyloid β oligomers in the brain , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[7]  R. Petersen,et al.  A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals , 2020, Scientific Reports.

[8]  K. Zahs,et al.  A Cautionary Tale: Endogenous Biotinylated Proteins and Exogenously-Introduced Protein A Cause Antibody-Independent Artefacts in Western Blot Studies of Brain-Derived Proteins , 2019, Biological Procedures Online.

[9]  K. Zahs,et al.  Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments , 2019, PloS one.

[10]  Y. Suh,et al.  Differential spatial expression of peripheral olfactory neuron-derived BACE1 induces olfactory impairment by region-specific accumulation of β-amyloid oligomer , 2017, Cell Death & Disease.

[11]  Peng Liu,et al.  Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice. , 2017, Journal of Alzheimer's disease : JAD.

[12]  M. Gairí,et al.  Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments , 2016, Proceedings of the National Academy of Sciences.

[13]  K. Rhodes,et al.  The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease , 2016, Nature.

[14]  K. Zahs,et al.  Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration. , 2015, Cell reports.

[15]  K. Zahs,et al.  Characterization of a Novel Mouse Model of Alzheimer’s Disease—Amyloid Pathology and Unique β-Amyloid Oligomer Profile , 2015, PloS one.

[16]  Urmi Sengupta,et al.  Tau Immunotherapy Modulates Both Pathological Tau and Upstream Amyloid Pathology in an Alzheimer's Disease Mouse Model , 2015, The Journal of Neuroscience.

[17]  Shaomin Li,et al.  Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity , 2014, Biochemistry.

[18]  David A Bennett,et al.  Brain amyloid-β oligomers in ageing and Alzheimer's disease. , 2013, Brain : a journal of neurology.

[19]  H. Vinters,et al.  AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly , 2012, Neurobiology of Aging.

[20]  N. Toni,et al.  An Effector-Reduced Anti-β-Amyloid (Aβ) Antibody with Unique Aβ Binding Properties Promotes Neuroprotection and Glial Engulfment of Aβ , 2012, The Journal of Neuroscience.

[21]  C. Cotman,et al.  Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines , 2012, Neurobiology of Aging.

[22]  R. Kayed,et al.  Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain*♦ , 2011, The Journal of Biological Chemistry.

[23]  K. Zahs,et al.  Grape seed polyphenolic extract specifically decreases aβ*56 in the brains of Tg2576 mice. , 2011, Journal of Alzheimer's disease : JAD.

[24]  Rie Teraoka,et al.  A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo , 2010, The Journal of Neuroscience.

[25]  L. Mucke,et al.  Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice , 2009, The Journal of Neuroscience.

[26]  C. Glabe,et al.  Structural Classification of Toxic Amyloid Oligomers* , 2008, Journal of Biological Chemistry.

[27]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[28]  D. Teplow,et al.  Grape-Derived Polyphenolics Prevent Aβ Oligomerization and Attenuate Cognitive Deterioration in a Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.

[29]  Dag Sehlin,et al.  Sensitive ELISA detection of amyloid‐β protofibrils in biological samples , 2007 .

[30]  Elizabeth Head,et al.  Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers , 2007, Molecular Neurodegeneration.

[31]  L. Mucke,et al.  Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.

[32]  J. D. McGaugh,et al.  Learning Decreases Aβ*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD Mice , 2007, The Journal of Neuroscience.

[33]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[34]  Charles Weissmann,et al.  The state of the prion , 2004, Nature Reviews Microbiology.

[35]  L. Mucke,et al.  Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation , 2004, Nature Medicine.

[36]  Kazuki Sato,et al.  Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[38]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[39]  George A. Carlson,et al.  The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[40]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[41]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[42]  M. Emmerling,et al.  Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[43]  T. Holzman,et al.  Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. , 1994, Biophysical journal.

[44]  C. Weissmann The prion's progress , 1991, Nature.

[45]  C. Weissmann Spongiform encephalopathies. The prion's progress. , 1991, Nature.

[46]  R. Morris Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.